Navigation Links
Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009
Date:7/9/2009

SHENZHEN, China, July 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the second quarter ended June 30, 2009 after the U.S. market closes on August 10, 2009. Mindray's management will hold an earnings conference call at 8:00 AM on August 11, 2009 U.S. Eastern Time (8:00 PM on August 11, 2009 Beijing/Hong Kong Time).

    Dial-in details for the earnings conference call are as follows:

    Hong Kong:                +852-3002-1672
    U.S. Toll Free:           +1-866-700-7477
    International:            +1-617-213-8840
    Passcode for all regions: Mindray

A replay of the conference call may be accessed by phone at the following numbers until August 22, 2009.

    U.S. Toll Free: +1-888-286-8010
    International:  +1-617-801-6888
    Passcode:       7624 2299

Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray's website at http://www.mindray.com .

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit '/>"/>

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mindray to Attend the 2009 American Association for Clinical Chemistry Conference
2. Mindray Announces First Quarter 2009 Financial Results
3. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
4. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
5. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
6. Mindray Announces Option Exchange Offer
7. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
8. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
9. Mindray Announces Preliminary 2008 Operating Results
10. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Switzerland (PRWEB) , ... September 01, 2015 , ... ... “Calibration and Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring ... presented on October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, ...
(Date:9/1/2015)... ... September 01, 2015 , ... METTLER ... now available. With the Connectivity Kit, EasySampler data is automatically transferred to, ... control experiment, on a touchscreen platform. , EasySampler fully automates the sampling ...
(Date:9/1/2015)... York, NY (PRWEB) , ... September 01, 2015 ... ... chosen as the 2015-2016 Distinguished Nurse Scholar-in Residence at the Institute of Medicine ... and Professor of Biomedical Informatics at Columbia University School of Nursing. A member ...
(Date:9/1/2015)... ... September 01, 2015 , ... Mercy Health (formerly Catholic Health ... 10th of its monthly Mercy Health: Helping You Be Well videos to prostate cancer ... men. , In a concise video on Mercy Health’s YouTube channel, Mercy Health ...
(Date:9/1/2015)... ... September 01, 2015 , ... CanAm ... investor-families have received permanent green cards (I-829 petition approval) from the USCIS through ... is the final step of the EB-5 visa process for immigrant investors to ...
Breaking Medicine News(10 mins):Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:Columbia Nursing’s Suzanne Bakken Named Distinguished Institute of Medicine Nurse Scholar-in-Residence 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2
... ... (AAE) for the second consecutive year. , ... Macau (PRWEB) June 28, 2009 -- Macau.com, the leading online destination marketing and ... Expo (AAE) for the second consecutive year., , , , ,As one of the ...
... ... This new web site, produced by a team of doctors and powered by a new ... for trusted health information in an accessible format that explains the medical meaning behind the ... Boston, MA (PRWEB) ...
... differentiate between healthy and abnormal cells , FRIDAY, June 26 ... sniff out cancer with a "chemical nose," a new report ... University of Massachusetts at Amherst say they have developed highly ... of a cell that indicate if it is healthy or ...
... ... 2009 American Orthopaedic Society for Sports Medicine (AOSSM) Hall of Fame inductees. , ... Keystone, CO (PRWEB) June 27, 2009 -- Giancarlo ... Hall of Fame inductees. Chosen for his vast research and instruction on knee surgery, Dr. Puddu ...
... intake of dietary fats from red meat and dairy products ... to a new study published online June 26 in the ... This study was undertaken because research relating fat intake to ... Z. Stolzenberg-Solomon, Ph.D., of the Division of Cancer Epidemiology and ...
... June 26 Marcus Rayner, executive director of the ... of individuals, businesses and organizations dedicated to improving the ... in the legislature and in the courts, today issued ... the company will immediately discontinue Accutane(R), a treatment for ...
Cached Medicine News:Health News:Macau.com Partners With Asia Adult Expo As Official Travel Company 2Health News:Macau.com Partners With Asia Adult Expo As Official Travel Company 3Health News:Michael Jackson Get the Medical Facts Behind the Headlines at CelebrityDiagnosis.com 2Health News:Michael Jackson Get the Medical Facts Behind the Headlines at CelebrityDiagnosis.com 3Health News:'Chemical Nose' May Sniff Out Cancer Earlier 2Health News:Internationally Renowned Orthopaedic Surgeon, Giancarlo Puddu, MD, Inducted into Sports Medicine Hall of Fame 2Health News:Dietary fat linked to pancreatic cancer 2
(Date:9/1/2015)... Pa. , Sept. 1, 2015 ... fully integrated specialty pharmaceutical company focused on discovering, ... that researchers will be  presenting scientific data on ... an abuse-deterrent, extended-release, oral morphine product candidate, and ... development, at PainWeek 2015 to be ...
(Date:9/1/2015)... - The ... egistry data presented at ESC Congress 2015 ... the evolution of manag ing AF in everyday ...   The first-ever two-year outcomes from the Global Anticoagulant Registry ... that all-cause death was the most frequent major event in more than 17,000 ...
(Date:9/1/2015)... Calif. , Sept. 1, 2015 /PRNewswire/ ... cardiovascular image management market, Frost & Sullivan ... 2015 European Frost & Sullivan Award for ... -based PMI has designed innovative and easy-to-use ... deliver precise and reproducible quantitative results for ...
Breaking Medicine Technology:Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 2Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 3Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 4Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 5
... organizer UBM Live announced strong booking levels ... buyers and sellers of high value chemistry. 248 exhibitors ... takes place from February 19th to 22nd of 2013 ... fine and specialty chemical companies that have signed up ...
... 15, 2012  Adamas Pharmaceuticals, Inc., a privately held ... End-of-Phase 2 meeting with the FDA to discuss ... conducted for the registration of Arimenda (memantine HCl ... once-daily fixed dose combination of extended release memantine ...
Cached Medicine Technology:Strong Booking Levels For Informex 2013 2Strong Booking Levels For Informex 2013 3Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™ 2Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™ 3
... All Infectious Disease ELISA ... well format. Also included ... positive and negative controls, ... stop solution. Use an ...
InBios' Trypanosoma cruzi (chagas disease) is an ELISA system for the detection of antibodies to T.cruzi derived TcF antigen in human serum or plasma This test is intended for professional in vitro d...
... chain reaction (PCR) technology, the worlds leading ... component of Roches blood screening assays and ... of selected unique regions of genetic material ... (that is, to detectable levels) in only ...
The OneTouch Flexx Professional Blood Glucose Monitoring System with OneTouchPro Test Strips sets the standard for safety and convenience with unique off-meter sample application and a wide range of ...
Medicine Products: